Co-founder and CEO of Cothera Bioscience

CEO/co-founder, Crown Bioscience, public listed on Taiwan Stock Exchange, in 2017 acquired by Japan-based JSR for US$400M CBO of Starvax Inc., an immuno-oncoligy company developing TLR9 agonist

Pattner, Burrril & Co.

COO, UniMicro, a medical device company

PhD & MBA - UC Berkeley

Founder of Cothera Bioscience

Co-founder and Chief Scientist of New Horizon Health

Co-founder and Chief Scientist of Crown Bioscience

Doctor of University of Utah, USA

Co-founder of Cothera Bioscience

25 years industry experience

Co-founder of multiple drug companies

Leader of product development of multiple marketed products
- Ceftaroline fosamil (Teflaro),
- Ceftolozane/tazobactam(Zerbaxa),
- Dalbacancin (Dalvance)

PhD - Duke University

Co-founder of Cothera Bioscience and General Manager of Percans Oncology

VP of Operation/co-founder, Crown Bioscience

Bachelor of Peking University